Skip to main content
. 2020 May 13;11:2399. doi: 10.1038/s41467-020-16118-7

Fig. 5. A neurotransmitter-sensitive AVATar.

Fig. 5

a Mechanism of dopamine-sensitive AVATars: PACAP (blue) is modified with a tethered dopamine (DA) analog (black), and a DA-binding IgG (green) functions as the blocking domain. Free neurotransmitter (red) competes with this interaction, releasing active PACAP. Structure of thiol-reactive tethered DA shown at bottom. b Titration of PACAP-10,20-DA in the PAC1 cell assay, showing efficient receptor activation. c PAC1 receptor activation by 1 nM PACAP-10,20-DA in the absence (blue) or presence (green) of 600 nM DA-binding IgG. Activity is restored by addition of excess DA (red). Control IgG (gray) does not block PACAP activity. d Titration of the DA response of 1 nM DA-AVATar in the PAC1 activation assay. DA activates DA-AVATar with an EC50 of 5.6 ± 0.5 µM. Error bars denote SD of duplicates.